When Cells Become Drugs: The Rise of Allogeneic CAR-T

CAR-T therapy introduced a radical idea: using living cells as medicine. Now, scientists are developing allogeneic CAR-T—an off-the-shelf version that could make cell therapy faster, more accessible, and more scalable. Discover how engineered immune cells are transforming cancer treatment and paving the way for a new generation of living medicines.